A Study to Evaluate Safety, Pharmacokinetic, and Biological Activity of INCB059872 in Subjects With Sickle Cell Disease
Clinical trial NCT03132324 · TERMINATED
Trial details
- NCT number
- NCT03132324
- Sponsor
- Incyte Corporation
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-20
- Primary completion
- 2018-10-03
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.